Douglas Evan Godshall, President & CEO at Shockwave Medical, Inc. (SWAV), sold 18,300 shares at $213.65 ($3.9M) on 2023-09-15, disclosed to the SEC on 2023-09-19.
Scheduled sale ($3.9M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.38 | 1,200 | $252K | 6.5% |
| 2 | $211.79 | 1,343 | $284K | 7.3% |
| 3 | $211.79 | 1,343 | $284K | 7.3% |
| 4 | $212.74 | 2,086 | $444K | 11.4% |
| 5 | $212.74 | 2,086 | $444K | 11.4% |
| 6 | $213.65 | 4,871 |
| $1.0M |
| 26.7% |
| 7 | $213.65 | 4,871 | $1.0M | 26.7% |
| 8 | $214.52 | 500 | $107K | 2.8% |
| Total | $212.98 avg | 18,300 | $3.9M | 100% |
| Filing → |
| SWAV | SELL | 2024-01-08 | $2.0M | — | Filing → |
| SWAV | SELL | 2023-12-18 | $1.7M | — | Filing → |
| SWAV | SELL | 2023-11-17 | $1.2M | — | Filing → |